Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-10 Sale | 2023-02-27 5:10 pm | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 6 | $15.21 | $91 | 0 (Indirect Direct) | View |
| 2022-01-11 Purchase | 2022-01-13 4:28 pm | CinCor Pharma Inc. | CINC | Freeman Mason EVP Clinical Development | 2,600 | $16 | $41,600 | 2,600 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-24 Equity Swap | 2023-02-27 5:10 pm | N/A N/A | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 2,594 | $0 | 0 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-27 5:10 pm | N/A 2029-09-24 | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 335,854 | $0 | 0 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 8:03 pm | N/A N/A | CinCor Pharma Inc. | CINC | Freeman Mason Chief Medical Officer | 40,000 | $0 | 42,600 (Direct) | View |
Ownership | 2022-01-06 8:49 pm | N/A 2029-09-24 | CinCor Pharma Inc. | CINC | Freeman Mason EVP Clinical Development | 0 | $0 | 295,854 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:15 pm | N/A 2030-06-09 | scPharmaceuticals Inc. | SCPH | Freeman Mason Director | 6,124 | $0 | 6,124 (Direct) | View |